Atika Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-65,000
| Closed | -$1.68M | – | 84 |
|
|
2021
Q1 | $1.68M | Sell |
65,000
-105,247
| -62% | -$2.72M | 0.15% | 75 |
|
|
2020
Q4 | $9.1M | Buy |
+170,247
| New | +$9.1M | 0.71% | 56 |
|
|
2020
Q3 | – | Sell |
-100,000
| Closed | -$4.85M | – | 89 |
|
|
2020
Q2 | $4.85M | Buy |
+100,000
| New | +$4.85M | 0.63% | 61 |
|
|
2017
Q2 | – | Sell |
-65,200
| Closed | -$2.24M | – | 66 |
|
|
2017
Q1 | $2.24M | Buy |
+65,200
| New | +$2.24M | 1.1% | 42 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 54 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 61 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 54 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 39 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 52 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 51 |
|
|
2015
Q2 | – | Sell |
-35,000
| Closed | -$1.14M | – | 60 |
|
|
2015
Q1 | $1.14M | Sell |
35,000
-83,500
| -70% | -$2.72M | 0.76% | 50 |
|
|
2014
Q4 | $3.76M | Sell |
118,500
-33,500
| -22% | -$1.06M | 2.75% | 9 |
|
|
2014
Q3 | $3.77M | Sell |
152,000
-43,000
| -22% | -$1.07M | 2.89% | 7 |
|
|
2014
Q2 | $4.41M | Buy |
195,000
+15,300
| +9% | +$346K | 3.58% | 4 |
|
|
2014
Q1 | $4.37M | Buy |
179,700
+4,725
| +3% | +$115K | 3.72% | 6 |
|
|
2013
Q4 | $4.37M | Buy |
+174,975
| New | +$4.37M | 3.89% | 4 |
|